Journal of Pharmaceutical and Biomedical Sciences

A Meta-analysis of Effectiveness Evaluation between Shexiang Baoxin Pill and Isosorbide Mononitrate Tablet

Bei Tan, Haihua Guo, Jie Jiang, Tiantian Zhang

Abstract


Objective To compare the efficacy of Shexiang Baoxin Pill (SBP) with isosorbide mononitrate tablet (ISM) in the clinical treatment of angina pectoris of coronary heart disease and the ratio of electrocardiogram (ECG) improvement in patients.

Methods Systematically searched EMBASE, MEDLINE, PubMed, CBM, VIP, Wanfang and CNKI databases from 2000 to 2016 to collect all relevant studies. According to the Cochrane Handbook for systematic reviews, quality assessment and data extraction were precise. All data were analyzed by using Review Manager 5.2.

Results The results showed that SBP had a significant effect on the total effective rate (7 trials, n = 874, OR = 0.31, 95% CI: 0.21–0.46, P < 0.05) and on the ECG improving rate (4 trials, n = 437, OR = 0.39, 95% CI: 0.20–0.49, P < 0.05), which compared with ISM in the clinical treatment of angina pectoris of coronary heart disease.

Conclusion SBP had a better effect than the ISM in the treatment of angina pectoris of coronary heart disease in terms of total effective rate and ECG improving rate.


Keywords


Shexiang Baoxin Pill, isosorbide mononitrat tablet, angina pectoris, coronary heart disease, meta-analysis

Full Text:

References


Su JX, Zhong ZY. The effects of Shexiang Baoxin pills with combination of Iscaorbide Dinitrater tabletin treatment of angina pectoris. J Liaoning Med University. 2010;31:212–214.

Zhao J. Clinical observation on 40 cases of coronary heart disease treated by Shexiang Baoxin pill and nitroglycerin. J Heilongjiang Med J. 2015;28:142–143.

Ning HH. Efficacy of Shexiang Tongxin drop pills treating angina pectori. Chin J Geriatric Care. 2012;10:46.

AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndrome distribution law in 507 coronary heart disease patients of the Han nationality in Fuzhou city. Chin J Inter Tradit West Med. 2011;6:756–759.

Guidelines for the diagnosis and treatment of chornic stable angina pectori. Chin J Cardiol. 2007;35:195–206.

Song H. Pharmacology studies and evaluation of clinical application on Shexiang Baoxin Pills. J Chinese Traditional Pat Med.2002;24:131–133.

Li J. Clinical analysis of Shexiang Baoxin pills in patients with angina pectoris of coronary heart disease. China Prac Med. 2013;8:176–177.

Zhang S. Clinical study on treatment of angina pectoris of coronary heart disease with Shexiang Baoxin pill combined with isosorbide mononitrate tablet. J Proc Clin Med. 2015;24:473–475.

Song L. Application of Shexiang Baoxin pills in patients with coronary heart disease. J Primary Med Forum. 2015;19: 2871–2872.

Xing J, Li L, Li R, et al. Clinical efficacy observation of Shexiang Baoxin pills on unstable angina. J Tianjin J Trad Chinese Med.2015;32:530–532.

Bai Y, Xu Y. Clinical study on the effect and safety of Shexiang Baoxin pill in treating coronary heart disease with stable angina pectoris. J Pharmacol Clin Chinese Materia Medica. 2015;31:308–309.

Luo L. Clinical efficacy observation of Shexiang Baoxin pill on angina pectoris of coronary heart disease. J Chinese Traditional Patent Med. 2003;25:984–986.

Li P, Dechun lv. Clinical observation on treatment of angina pectoris of coronary heart disease with Shexiang Baoxin pills.J Contemp Med. 2012;18:154–155.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.